Skip to main content

Carna Biosciences to Supply Reagents to Caliper

NEW YORK (GenomeWeb News) – Carna Biosciences will supply Caliper Life Sciences with a discrete set of protein kinases for use in its profiling and assay development services, and for its ProfilerPro Kits, Carna said today.
 
Kobe, Japan-based Carna provides products and services including protein kinases, profiling and screening services, assay development services, and crystallography products and services.
 
Carna said that the Caliper agreement will give the company new opportunities to sell its protein kinases on the worldwide market, and that it will help position the company for supply agreements with pharmaceutical companies.
 
Financial terms of the agreement were not released.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.